Zymergi LogoCart

483 Document: Amphastar Pharmaceuticals, Inc., Mar 1, 2024

FDANews 483 Amphastar Pharmaceuticals, Inc. Mar 1 2024 top
Crystal Monroy FDA Investigator Uttaniti Limchumroon FDA Investigator Walden H. Lee FDA Investigator Lillian S. Wu FDA Investigator Rachel C. Stanton FDA Investigator Michael T. Cyrus FDA Investigator Homero W. Aguilar FDA Investigator

On Mar 01, 2024, the FDA inspected Amphastar Pharmaceuticals, Inc.'s Rancho Cucamonga site. Explore the inspectional observations.